An effective human uracil-DNA glycosylase inhibitor targets the open pre-catalytic active site conformation
My T. Nguyen(Case Western Reserve University), Stanton L. Gerson(Case Western Reserve University), Daniel J. Laverty(Massachusetts Department of Public Health), Sarita Namjoshi(The University of Texas MD Anderson Cancer Center), Edward J. Selvik(University of Arkansas for Medical Sciences), Dave S. Shin(Lawrence Berkeley National Laboratory), Yuriy Fedorov(Case Western Reserve University), John A. Tainer(The University of Texas MD Anderson Cancer Center), Andy Arvai(Scripps Research Institute), Davide Moiani(The University of Texas MD Anderson Cancer Center), Zachary D. Nagel(Harvard University), Zamal Ahmed(The University of Texas MD Anderson Cancer Center), John J. Pink(Case Western Reserve University), Yan Yan(Jacksonville College), Darin E. Jones(University of Arkansas at Little Rock)
Cited by 28
Related Papers
Microbial metalloproteomes are largely uncharacterized
|Nature|2010|363
Comparison of <i>O<sup>6</sup></i>-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues
|Carcinogenesis|1986|274
Future cancer research priorities in the USA: a Lancet Oncology Commission
|The Lancet Oncology|2017|209
Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
|Nature Communications|2019|135